Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -22,811 | -4,003 | -5,387 | N/A |
| Depreciation Amortization | 391 | N/A | N/A | N/A |
| Accounts receivable | -265 | -838 | -851 | N/A |
| Accounts payable and accrued liabilities | 590 | 33 | 257 | N/A |
| Other Working Capital | -3,040 | 1,110 | 2,664 | N/A |
| Other Operating Activity | 2,620 | 1,299 | 305 | 0 |
| Operating Cash Flow | $-22,515 | $-2,399 | $-3,012 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -163,278 | N/A | N/A | N/A |
| PPE Investments | -522 | N/A | N/A | N/A |
| Investing Cash Flow | $-163,800 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 2,400 | N/A | N/A |
| Common Stock Issued | 107 | 1 | N/A | N/A |
| Other Financing Activity | 239,203 | 0 | 1,965 | 0 |
| Financing Cash Flow | $239,310 | $2,401 | $1,965 | $N/A |
| Beginning Cash Position | 1,121 | 1,119 | 2,166 | N/A |
| End Cash Position | 54,116 | 1,121 | 1,119 | N/A |
| Net Cash Flow | $52,995 | $2 | $-1,047 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -22,515 | -2,399 | -3,012 | N/A |
| Capital Expenditure | -522 | N/A | N/A | N/A |
| Free Cash Flow | -23,037 | -2,399 | -3,012 | 0 |